Chemistry Wealth Management LLC Lowers Holdings in Oracle Corporation $ORCL

Chemistry Wealth Management LLC decreased its holdings in Oracle Corporation (NYSE:ORCL) by 0.4% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 34,117 shares of the enterprise software provider’s stock after selling 140 shares during the quarter. Oracle accounts for about 1.6% of Chemistry Wealth Management LLC’s holdings, making the stock its 13th biggest holding. Chemistry Wealth Management LLC’s holdings in Oracle were worth $7,459,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in ORCL. Nuveen LLC purchased a new position in shares of Oracle in the first quarter valued at approximately $732,692,000. GAMMA Investing LLC lifted its stake in Oracle by 15,012.3% in the first quarter. GAMMA Investing LLC now owns 4,755,096 shares of the enterprise software provider’s stock worth $664,810,000 after acquiring an additional 4,723,631 shares during the last quarter. Vanguard Group Inc. lifted its stake in Oracle by 2.2% in the first quarter. Vanguard Group Inc. now owns 160,925,413 shares of the enterprise software provider’s stock worth $22,498,982,000 after acquiring an additional 3,513,464 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in Oracle by 20.5% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 13,825,360 shares of the enterprise software provider’s stock worth $2,303,858,000 after acquiring an additional 2,350,448 shares during the last quarter. Finally, Mitsubishi UFJ Asset Management Co. Ltd. lifted its stake in Oracle by 79.2% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 4,638,951 shares of the enterprise software provider’s stock worth $648,572,000 after acquiring an additional 2,049,687 shares during the last quarter. Hedge funds and other institutional investors own 42.44% of the company’s stock.

Wall Street Analyst Weigh In

ORCL has been the subject of a number of recent research reports. KeyCorp lifted their price target on shares of Oracle from $200.00 to $225.00 and gave the stock an “overweight” rating in a research note on Thursday, June 12th. Westpark Capital raised their price objective on shares of Oracle from $195.00 to $246.00 and gave the stock a “buy” rating in a report on Thursday, June 12th. Morgan Stanley raised their price objective on shares of Oracle from $175.00 to $246.00 and gave the stock an “equal weight” rating in a report on Monday, September 8th. Scotiabank reissued an “outperform” rating on shares of Oracle in a report on Wednesday. Finally, Oppenheimer reaffirmed an “outperform” rating on shares of Oracle in a report on Wednesday, June 18th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty-five have given a Buy rating and eight have issued a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $296.84.

Insider Activity at Oracle

In related news, Director Rona Alison Fairhead bought 480 shares of the firm’s stock in a transaction on Monday, July 7th. The shares were bought at an average cost of $233.87 per share, for a total transaction of $112,257.60. Following the transaction, the director owned 22,110 shares of the company’s stock, valued at approximately $5,170,865.70. This trade represents a 2.22% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Michael D. Sicilia sold 15,880 shares of the business’s stock in a transaction on Tuesday, August 5th. The stock was sold at an average price of $254.48, for a total transaction of $4,041,142.40. Following the sale, the insider owned 99,212 shares in the company, valued at $25,247,469.76. The trade was a 13.80% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 44,183 shares of company stock worth $10,353,198. 42.20% of the stock is currently owned by insiders.

Oracle Stock Performance

Shares of ORCL opened at $292.07 on Monday. The company has a debt-to-equity ratio of 3.33, a quick ratio of 0.62 and a current ratio of 0.62. The stock has a market capitalization of $829.98 billion, a P/E ratio of 67.61, a P/E/G ratio of 3.16 and a beta of 1.46. The company’s fifty day moving average is $244.69 and its two-hundred day moving average is $190.68. Oracle Corporation has a 1 year low of $118.86 and a 1 year high of $345.72.

Oracle Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, October 23rd. Shareholders of record on Thursday, October 9th will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Thursday, October 9th. Oracle’s payout ratio is presently 46.30%.

About Oracle

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.